1. Indian Government to Set Trade Margins of 50 Orphan Drugs, Treatments for Cancer and Rare Diseases

Published: 25 Jan, 2019 | Tags: Indian Government, Set, Trade, Margins, 50, Orphan Drugs, Treatments, Cancer, Rare, Diseases    

2. Medtronic to Acquire EPIX Therapeutics for its Cardiovascular Technologies

Published: 25 Jan, 2019 |  Tags: Medtronic, Acquire, EPIX Therapeutics, Cardiovascular, Technologies, Diamond Temp Ablation system, Arctic Front Advance Cryoablation System    

3. Clovis Oncology’s Rubraca (Rucaparib) Receives EU Approval for Maintenance Treatment of Relapsed Ovarian Cancer (OC) in Adults

Published: 25 Jan, 2019 | Tags: Clovis Oncology, Rubraca, (Rucaparib), Receives, EU, Approval, Maintenance, Treatment, Relapse, Ovarian Cancer, OC, Adults

4. Amgen’s Repatha (evolocumab) Receives NMPA (CFDA) Approval for Reduction of Cardiovascular Risks in China

Published: 24 Jan, 2019 | Tags: Amgen, Reports, Safety, Efficacy, Results, Repatha, (evolocumab), OSLER-1, Five-Year Extension Study, GOULD    

5. Roche and Basilea Sign a Research Collaboration to Evaluate Derazantinib + Tecentriq (atezolizumab) in Patients with Urothelial Cancer (UC)

Published: 24 Jan, 2019 | Tags: Basilea, Roche, Collaborates, study, Derazantinib, Tecentriq, atezolizumab, Urothelial Cancer, (UC)  

6. Amgen and Allergan Reports Results of ABP 798 (rituximab, biosimilar) in P-I/III (NCT02792699) for Moderate-To-Severe Rheumatoid Arthritis (RA)

Published: 24 Jan, 2019 |Tags: Allergan, Announces, Completion, UBR-MD-04 & 3110-105-002 Study, Treatment, Migrane, Ubrogepant  

7. Philogen Collaborates with Johnson&Johnson (J&J), Novartis and Celgene

Published: 23 Jan, 2019 |Tags: Medtronic, Acquire, EPIX Therapeutics, Cardiovascular, Technologies, DiamondTemp Ablation system, Arctic Front Advance Cryoablation System  

8. Athersys Reports results of Multistem Cell Therapy (IV) in Patients with Acute Respiratory Distress Syndrome (ARDS)

Published: 24 Jan, 2019 |Tags: Athersys, Reports, Results, Multistem Cell Therapy, (IV), Acute Respiratory Distress Syndrome, (ARDS)  

9. B-MoGen Biotechnologies and CytoSen Therapeutics Signs an Agreement for the Development of Gene-Modified Therapies

Published: 23 Jan, 2019 |Tags: B-MoGen Biotechnologies and CytoSen Therapeutics Signs an Agreement for the Development of Gene-Modified Therapies  

10. 23andMe’s MAP Report Receives FDA’s 510(k) Clearance for Hereditary Colorectal Cancers

Published: 22 Jan, 2019 |Tags: 23andMe, MAP Report, Receives, FDA 510(k) Clearance, Hereditary Colorectal Cancers, BRCA1/BRCA2